101 related articles for article (PubMed ID: 24450628)
21. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
[TBL] [Abstract][Full Text] [Related]
22. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
23. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
24. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
25. [Immune Regulation by TNF Receptor-associated Factor 5].
So T
Yakugaku Zasshi; 2024; 144(5):489-496. PubMed ID: 38692922
[TBL] [Abstract][Full Text] [Related]
26. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H
Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375
[TBL] [Abstract][Full Text] [Related]
27. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
28. Activation of RAW264.7 mouse macrophage cells in vitro through treatment with recombinant ricin toxin-binding subunit B: involvement of protein tyrosine, NF-κB and JAK-STAT kinase signaling pathways.
Xu N; Yuan H; Liu W; Li S; Liu Y; Wan J; Li X; Zhang R; Chang Y
Int J Mol Med; 2013 Sep; 32(3):729-35. PubMed ID: 23820591
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 as a therapy target in oral squamous carcinoma.
Culig Z
Expert Opin Ther Targets; 2013 Jan; 17(1):53-9. PubMed ID: 23101455
[TBL] [Abstract][Full Text] [Related]
30. Systems biology of JAK/STAT signalling.
Pfeifer AC; Timmer J; Klingmüller U
Essays Biochem; 2008; 45():109-20. PubMed ID: 18793127
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation.
Meyer AN; Gallo LH; Ko J; Cardenas G; Nelson KN; Siari A; Campos AR; Whisenant TC; Donoghue DJ
PLoS One; 2018; 13(10):e0206014. PubMed ID: 30335863
[TBL] [Abstract][Full Text] [Related]
33. GP130 signaling and the control of naïve pluripotency in humans, monkeys, and pigs.
Bourillot PY; Santamaria C; David L; Savatier P
Exp Cell Res; 2020 Jan; 386(1):111712. PubMed ID: 31697928
[TBL] [Abstract][Full Text] [Related]
34. Differential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantation.
Kroy DC; Hebing L; Sander LE; Gassler N; Erschfeld S; Sackett S; Galm O; Trautwein C; Streetz KL
PLoS One; 2012; 7(6):e39728. PubMed ID: 22745821
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 signalling in health and disease.
Rose-John S
F1000Res; 2020; 9():. PubMed ID: 32864098
[TBL] [Abstract][Full Text] [Related]
36. Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.
Shankar A; McAlees JW; Lewkowich IP
J Allergy Clin Immunol; 2022 Aug; 150(2):266-276. PubMed ID: 35934680
[TBL] [Abstract][Full Text] [Related]
37. IL-13 Inhibits Multicilin Expression and Ciliogenesis via Janus Kinase/Signal Transducer and Activator of Transcription Independently of Notch Cleavage.
Gerovac BJ; Fregien NL
Am J Respir Cell Mol Biol; 2016 Apr; 54(4):554-61. PubMed ID: 26414872
[TBL] [Abstract][Full Text] [Related]
38. Molecular and cellular factors determining the functional pleiotropy of cytokines.
McFarlane A; Pohler E; Moraga I
FEBS J; 2023 May; 290(10):2525-2552. PubMed ID: 35246947
[TBL] [Abstract][Full Text] [Related]
39. Making sense of IL-6 signalling cues in pathophysiology.
Millrine D; Jenkins RH; Hughes STO; Jones SA
FEBS Lett; 2022 Mar; 596(5):567-588. PubMed ID: 34618359
[TBL] [Abstract][Full Text] [Related]
40. Insights into IL-23 biology: From structure to function.
Floss DM; Schröder J; Franke M; Scheller J
Cytokine Growth Factor Rev; 2015 Oct; 26(5):569-78. PubMed ID: 26195433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
